PURE Bioscience, Inc.
General ticker "PURE" information:
- Sector: Consumer Staples
- Industry: Household Products
- Capitalization: $8.8M (TTM average)
PURE Bioscience, Inc. follows the US Stock Market performance with the rate: 5.9%.
Estimated limits based on current volatility of 4.1%: low 0.05$, high 0.05$
Factors to consider:
- Total employees count: 11 (0.0%) as of 2024
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Demonstrating product effectiveness, Market entry risks, Raising sufficient funds, Converting trials to orders, Sales and marketing experience
- Price in estimated range
- Earnings for 15 months up through Q1 (+1 year) are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-07-31 to 2026-07-31
- 2024-07-31 to 2025-07-31 estimated range: [0.04$, 0.13$]
- 2025-07-31 to 2026-07-31 estimated range: [0.04$, 0.12$]
Financial Metrics affecting the PURE estimates:
- Positive: with PPE of -1.8 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -30.71 <= 0.33
- Positive: Investing cash flow per share per price, % of 0 > -0.66
- Positive: Interest expense per share per price, % of 1.88 <= 3.41
- Positive: Inventory ratio change, % of -1.70 <= -0.75
- Negative: Shareholder equity ratio, % of -350.12 <= 18.93
- Negative: Industry operating cash flow per share per price (median), % of 2.76 <= 5.52
Short-term PURE quotes
Long-term PURE plot with estimates
Financial data
| YTD | 2022-07-31 | 2023-07-31 | 2024-07-31 |
|---|---|---|---|
| Operating Revenue | $1.85MM | $1.88MM | $1.96MM |
| Operating Expenses | $5.58MM | $5.82MM | $5.15MM |
| Operating Income | $-3.72MM | $-3.94MM | $-3.19MM |
| Non-Operating Income | $0.23MM | $-0.02MM | $-0.16MM |
| Interest Expense | $0.01MM | $0.01MM | $0.15MM |
| R&D Expense | $0.32MM | $0.30MM | $0.30MM |
| Income(Loss) | $-3.49MM | $-3.96MM | $-3.35MM |
| Profit(Loss)* | $-3.50MM | $-3.96MM | $-3.35MM |
| Stockholders Equity | $3.91MM | $0.27MM | $-2.86MM |
| Inventory | $0.18MM | $0.09MM | $0.06MM |
| Assets | $4.48MM | $1.82MM | $0.82MM |
| Operating Cash Flow | $-2.42MM | $-3.28MM | $-2.53MM |
| Capital expenditure | $0.08MM | $0.03MM | $0.00MM |
| Investing Cash Flow | $-0.08MM | $-0.03MM | $0.00MM |
| Financing Cash Flow | $3.50MM | $1.01MM | $1.78MM |
| Earnings Per Share** | $-0.04 | $-0.04 | $-0.03 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.